Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532863) titled 'A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants' on April 6.

Study Type: Observational

Primary Sponsor: Novo Nordisk A/S

Condition: Diabetes Mellitus, Type 2

Intervention: Other: No treatment given

Recruitment Status: Recruiting

Date of First Enrollment: March 13, 2026

Target Sample Size: 400

Countries of Recruitment: Singapore

To know more, visit https://clinicaltrials.gov/study/NCT07532863

Disclaimer: Curated by HT Syndication....